Yahoo
Jakarta - Delayed Quote IDR

PT Sejahteraraya Anugrahjaya Tbk (SRAJ.JK)

10,350.00 -50.00 (-0.48%)
At close: 9:57:13 AM GMT+7
Chart Range Bar
Loading chart for SRAJ.JK
  • Previous Close 10,400.00
  • Open 10,350.00
  • Bid 9,925.00 x --
  • Ask 10,250.00 x --
  • Day's Range 10,350.00 - 10,350.00
  • 52 Week Range 8,525.00 - 19,200.00
  • Volume 100
  • Avg. Volume 3,417
  • Market Cap (intraday) 126.673T
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -37.52
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. The company manages and operates hospitals under the Mayapada Hospital name for neuroscience center, uro-nephrology center, cardiovascular center, gastro hepatology center, liver center, oncology center, orthopedic center, spine and arthroplasty center, obstetrics and gynecology center, internal medicine and pulmonology, pediatric center, aesthetic center, sports injury treatment and performance center, rehabilitation center, and immunology center. The company was formerly known as PT Sejahtera Raya Anugrah and changed its name to PT Sejahteraraya Anugrahjaya Tbk in December 1992. PT Sejahteraraya Anugrahjaya Tbk was founded in 1991 and is based in Tangerang, Indonesia. PT Sejahteraraya Anugrahjaya Tbk is a subsidiary of PT Surya Cipta Inti Cemerlang.

www.mayapadahospital.com

4,478

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

SRAJ.JK
37.27%
IDX COMPOSITE (^JKSE)
41.83%

1-Year Return

SRAJ.JK
13.75%
IDX COMPOSITE (^JKSE)
39.53%

3-Year Return

SRAJ.JK
2,908.72%
IDX COMPOSITE (^JKSE)
25.90%

5-Year Return

SRAJ.JK
2,461.88%
IDX COMPOSITE (^JKSE)
23.57%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.83%

  • Return on Assets (ttm)

    -0.96%

  • Return on Equity (ttm)

    -37.64%

  • Revenue (ttm)

    2.72T

  • Net Income Avi to Common (ttm)

    -458.66B

  • Diluted EPS (ttm)

    -37.52

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.4T

  • Total Debt/Equity (mrq)

    611.03%

  • Levered Free Cash Flow (ttm)

    -746.07B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: